Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/22431
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vianna, Joao L. | cat |
dc.contributor.author | Haga, Hans J. | cat |
dc.contributor.author | Tripathi, Poonam | cat |
dc.contributor.author | Cervera i Segura, Ricard, 1960- | cat |
dc.contributor.author | Khamashta, Munther A. | cat |
dc.contributor.author | Hughes, Graham R. V. (Graham Robert Vivian) | cat |
dc.date.accessioned | 2012-03-05T12:52:01Z | - |
dc.date.available | 2012-03-05T12:52:01Z | - |
dc.date.issued | 1992 | - |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.uri | http://hdl.handle.net/2445/22431 | - |
dc.description.abstract | The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work. | eng |
dc.format.extent | 2 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | eng |
dc.publisher | BMJ Group | - |
dc.relation.isformatof | Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.51.2.160 | - |
dc.relation.ispartof | Annals of the Rheumatic Diseases, 1992, vol. 51, núm. 2, p. 160-161 | - |
dc.relation.uri | http://dx.doi.org/10.1136/ard.51.2.160 | - |
dc.rights | (c) BMJ Publishing Group Ltd, 1992 | - |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Lupus eritematós | cat |
dc.subject.classification | Síndrome antifosfolipídica | cat |
dc.subject.classification | Estudi de casos | cat |
dc.subject.other | Lupus erythematosus | eng |
dc.subject.other | Antiphospholipid syndrome | eng |
dc.subject.other | Case studies | eng |
dc.title | Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. | eng |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 562698 | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 1550396 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
562698.pdf | 400.41 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.